Rheumatology · Spring Hill, FL
NPI
1770523144
Since 2006
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11325 Cortez Blvd
Spring Hill, FL, 34613
Phone (352) 596-6333
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
432,337 services
Medicare patients, 2024
593
Average age 73
Drug cost, 2024
$2.4M
4,172 prescriptions
Company payments, 2025
$562
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anas Moureiden was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 226,820 times for 70 patients. In total Anas Moureiden billed 432,337 services in 15 codes, and Medicare paid $1.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 226,820 | 70 | $3.61 | $820K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 185,993 | 478 | $0.11 | $20K |
| 89051 Blood Count | Office | 3,826 | 543 | $5.49 | $21K |
| 89060 Test - Miscellaneous | Office | 3,819 | 543 | $7.18 | $27K |
| 20610 Joint Injection | Office | 2,947 | 510 | $34.90 | $103K |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 2,061 | 412 | $6.86 | $14K |
| 99214 Office E&M - Established | Office | 2,042 | 576 | $90.85 | $186K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 1,849 | 531 | $1.00 | $1,846 |
| 96372 Injection Administration | Office | 1,143 | 75 | $10.56 | $12K |
| 20605 Joint Injection | Office | 967 | 316 | $21.50 | $21K |
| 96161 E&M - Miscellaneous | Office | 769 | 400 | $0.77 | $595 |
| 99204 Office E&M - New | Office | 91 | 91 | $115.18 | $10K |
By year: 2022 $1.2M for 187,887 services; 2023 $1.2M for 223,538 services; 2024 $1.2M for 432,337 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 89051 Blood Count | 3,826 | 543 | $5.49 | $21K |
Medicare prescription drug claims, 2024
In 2024, the drug Anas Moureiden prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 704 prescriptions and refills. In total Anas Moureiden wrote 4,172 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 704 | 1,711 | 212 | $21K |
| Prednisone Generic | 379 | 856 | 168 | $3,947 |
| Hydroxychloroquine Sulfate Generic | 243 | 709 | 84 | $11K |
| Leflunomide Generic | 219 | 554 | 66 | $20K |
| Methylprednisolone Generic | 206 | 206 | 135 | $1,333 |
| Gabapentin Generic | 182 | 474 | 68 | $3,152 |
| Sulfasalazine Dr Sulfasalazine | 146 | 414 | 57 | $11K |
| Duloxetine Hcl Generic | 124 | 275 | 29 | $2,875 |
| Sulfasalazine Generic | 116 | 299 | 33 | $5,444 |
| Famotidine Generic | 109 | 320 | 50 | $1,336 |
| Folic Acid Generic | 78 | 216 | 26 | $1,309 |
| Azathioprine Generic | 77 | 222 | 27 | $2,723 |
| Meloxicam Generic | 69 | 173 | 33 | $365 |
| Potassium Chloride Generic | 69 | 174 | 21 | $2,499 |
| Otezla Apremilast | 64 | 72 | Under 11 | $350K |
Brand drugs: 714 claims; generic drugs: 3,424 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anas Moureiden $562 ($562 in general payments such as food, travel and fees) from 6 companies. The largest payer was Novartis Pharmaceuticals Corporation with $270.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.